GenQA

EQAs

GenQA provides a wide range of genomic external quality assessments (EQAs) for both laboratory based services, clinical genetics centres and individual assessment.
Full details of all EQAs availabe can be accessed by clicking on the relevant links below.

All EQAs scheduled for release during April, May and June 2020 are now POSTPONED. Details of the revised timetable are available HERE

Last updated: Monday, 08 June 2020

2020-21 Colorectal cancer - core Molecular testing of colorectal cancer. KRAS, NRAS and BRAF testing. Read more	2020-21 Colorectal cancer - Extended MMR Molecular testing of colorectal cancer. KRAS, NRAS, BRAF, MSI and MLH1 promoter methylation testing. Read more
2020-21 Colorectal cancer - MMR Molecular testing of colorectal cancer. KRAS, NRAS, BRAF and MLH1 promoter methylation testing. Read more	2020-21 Lung cancer - comprehensive Molecular testing of lung cancer. EGFR, ALK, ROS1, BRAF, KRAS, MET, RET, PIK3CA testing. Read more
2020-21 Lung cancer - core Molecular testing of lung cancer. EGFR, ALK, ROS1 Read more	2020-21 Lung cancer - EGFR only Molecular testing of lung cancer - testing of EGFR only. Read more
2020-21 Lung cancer - fusions Molecular testing of lung cancer. ALK, ROS1, MET and RET Read more	2020-21 MCADD blood spot Molecular testing of newborn screening cards for ACADM variants, including c.985A>G p.(Lys329Glu), to determine their heterozygous/homozyous state. Read more
2020-21 Melanoma Molecular testing of Melanoma. Read more	2020-21 SCID blood spot (pilot) Molecular testing of newborn screening cards for TREC levels associated with Severe Combined Immunodeficiency (SCID). Read more

Pages